These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 517190)

  • 21. Cytotoxic activity of rheumatoid and normal lymphocytes against allogeneic and autologous synovial cells in vitro.
    Griffiths MM; Smith CB; Ward JR; Klauber MR
    J Clin Invest; 1976 Sep; 58(3):613-22. PubMed ID: 956390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay.
    Bradley TP; Bonavida B
    Cell Immunol; 1984 Jan; 83(1):199-207. PubMed ID: 6420079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T; Mizuno F; Osato T
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A microcytotoxicity assay for thyroid-specific cytotoxic antibody, antibody-dependent cell-mediated cytotoxicity and direct lymphocyte cytotoxicity using human thyroid cells.
    Iwatani Y; Amino N; Mori H; Asari S; Matsuzuka F; Kuma K; Miyai K
    J Immunol Methods; 1982; 48(2):241-50. PubMed ID: 6895761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic and functional characterisation of tumour-infiltrating lymphocytes derived from thyroid tumours.
    Lee RS; Schlumberger M; Caillou B; Pages F; Fridman WH; Tartour E
    Eur J Cancer; 1996 Jun; 32A(7):1233-9. PubMed ID: 8758259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus-mediated induction in human lymphocytes of antibody-independent cytotoxicity (VDCC) and enhancement of antibody-dependent cytotoxicity (ADCC) against natural killer-resistant tumor target cells.
    Alsheikhly AR; Andersson T; Perlmann P
    Cell Immunol; 1984 Oct; 88(2):511-20. PubMed ID: 6488328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations.
    Kataki A; Skandami V; Memos N; Nikolopoulou M; Oikonomou V; Androulis A; Konstadoulakis MM; Zografos CG
    J Neurosurg Sci; 2014 Mar; 58(1):9-15. PubMed ID: 24614787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines.
    Zarling JM; Bach FH
    J Exp Med; 1978 May; 147(5):1334-40. PubMed ID: 206649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated cytotoxicity for cultured autologous melanoma cells.
    Livingston PO; Shiku H; Bean MA; Pinsky CM; Oettgen HF; Old LJ
    Int J Cancer; 1979 Jul; 24(1):34-44. PubMed ID: 478690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.
    Knuth A; Danowski B; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3511-5. PubMed ID: 6610177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
    Mukherji B; Wilhelm SA; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human tumour--lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells.
    Vose BM; Vánky F; Klein E
    Int J Cancer; 1977 Dec; 20(6):895-902. PubMed ID: 591128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering.
    Platsoucas CD
    Eur J Immunol; 1984 Jun; 14(6):566-77. PubMed ID: 6610558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
    Wilhelm SA; Mukherji B
    J Clin Invest; 1985 Apr; 75(4):1162-8. PubMed ID: 3988936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic lymphocyte cytotoxicity (ALC) in rats: establishment of an in vitro assay, and direct evidence that cells with natural killer (NK) activity are involved in ALC.
    Rolstad B; Fossum S
    Immunology; 1987 Feb; 60(2):151-7. PubMed ID: 2434415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels of cytotoxic reactivity to cultured normal skin fibroblasts in sera from normal and sarcoma-bearing patients.
    Catapano MS; Brown JM; Rosenberg SA
    Cancer Res; 1980 Apr; 40(4):979-83. PubMed ID: 6928402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in the immune status of patients with brain tumors in the pre- and postoperative periods].
    Lisianyĭ NI; Romodanov SA; Trosh RM; Rudenko VA; Radzievskiĭ AA
    Zh Vopr Neirokhir Im N N Burdenko; 1991; (4):19-21. PubMed ID: 1659076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
    Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
    J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.